IRIS
LASCO, Antonino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.922
NA - Nord America 8.179
AS - Asia 4.494
SA - Sud America 1.422
Continente sconosciuto - Info sul continente non disponibili 329
AF - Africa 112
OC - Oceania 10
Totale 23.468
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.005
RU - Federazione Russa 4.652
SG - Singapore 1.841
CN - Cina 1.454
BR - Brasile 1.180
IE - Irlanda 1.083
SE - Svezia 950
DE - Germania 566
IT - Italia 503
HK - Hong Kong 441
FR - Francia 327
FI - Finlandia 246
VN - Vietnam 246
GB - Regno Unito 169
UA - Ucraina 136
IN - India 135
PL - Polonia 106
AR - Argentina 84
CA - Canada 83
BD - Bangladesh 58
TR - Turchia 53
EC - Ecuador 45
IQ - Iraq 41
MX - Messico 39
BE - Belgio 34
NL - Olanda 34
VE - Venezuela 30
PK - Pakistan 28
JP - Giappone 24
ES - Italia 23
ZA - Sudafrica 23
CO - Colombia 22
ID - Indonesia 21
MA - Marocco 21
CL - Cile 20
UZ - Uzbekistan 20
PY - Paraguay 17
EG - Egitto 15
AT - Austria 14
CZ - Repubblica Ceca 14
JO - Giordania 14
PH - Filippine 13
SA - Arabia Saudita 13
UY - Uruguay 12
CI - Costa d'Avorio 10
JM - Giamaica 10
AZ - Azerbaigian 9
CH - Svizzera 9
DZ - Algeria 9
LT - Lituania 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
GT - Guatemala 8
KE - Kenya 8
NP - Nepal 8
KZ - Kazakistan 7
SN - Senegal 7
AL - Albania 6
BG - Bulgaria 6
CU - Cuba 6
DO - Repubblica Dominicana 6
HN - Honduras 6
IL - Israele 6
IR - Iran 6
KG - Kirghizistan 6
KR - Corea 6
MY - Malesia 6
PE - Perù 6
TN - Tunisia 5
BH - Bahrain 4
BO - Bolivia 4
ET - Etiopia 4
HU - Ungheria 4
NI - Nicaragua 4
RO - Romania 4
BN - Brunei Darussalam 3
DK - Danimarca 3
EE - Estonia 3
GE - Georgia 3
GR - Grecia 3
LV - Lettonia 3
NG - Nigeria 3
NO - Norvegia 3
XK - ???statistics.table.value.countryCode.XK??? 3
BY - Bielorussia 2
CR - Costa Rica 2
GY - Guiana 2
HR - Croazia 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
MU - Mauritius 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AM - Armenia 1
Totale 23.118
Salva come PNG Salva come JPEG
Città #
Moscow 1.256
Ashburn 1.147
Dublin 1.080
Singapore 1.027
Chandler 781
Dallas 699
Nyköping 514
Beijing 504
Hong Kong 415
San Jose 413
Jacksonville 374
Munich 257
The Dalles 241
Council Bluffs 228
Princeton 194
Dearborn 190
Los Angeles 166
New York 159
Medford 153
Lauterbourg 148
Messina 147
Ann Arbor 145
Cambridge 133
Bremen 124
Des Moines 118
Boardman 102
Warsaw 92
São Paulo 91
Ho Chi Minh City 85
Helsinki 79
Guangzhou 72
Jinan 67
Buffalo 63
Tianjin 63
Santa Clara 58
Shenyang 57
Hanoi 54
Turku 54
Nanjing 50
San Mateo 48
Frankfurt am Main 46
Wilmington 46
Catania 44
Pune 43
Redondo Beach 43
Orem 42
Houston 41
Atlanta 37
Lancaster 36
Woodbridge 36
Seattle 35
Rio de Janeiro 34
Brussels 33
Belo Horizonte 30
Curitiba 29
Hebei 28
Zhengzhou 27
Haikou 26
Hangzhou 25
Montreal 25
Brasília 24
Brooklyn 24
Chennai 24
Nanchang 24
Boston 23
Düsseldorf 23
Nuremberg 21
Taizhou 21
Baghdad 20
London 19
San Francisco 19
Denver 18
Hyderabad 18
Porto Alegre 18
Strasbourg 18
Tashkent 18
Johannesburg 17
Quito 17
Tokyo 17
Chicago 16
Milan 16
Ningbo 16
Fuzhou 15
Poplar 15
Toronto 15
Amsterdam 14
Jiaxing 14
Goiânia 13
Manchester 13
Rome 13
Shanghai 13
Taiyuan 13
Lahore 12
Manaus 12
Phoenix 12
Stockholm 12
Ankara 11
Changsha 11
Istanbul 11
Lanzhou 11
Totale 13.015
Salva come PNG Salva come JPEG
Nome #
ANXIETY LEVELS ARE ASSOCIATED WITH FRACTURE RISK IN POSTMENOPAUSAL WOMEN 301
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 298
Anxiety levels as risk factor for osteoporosis in postmenopausal women 279
SCLEROSTIN AND DICKKOPF-1 LEVELS IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 272
Circulating sclerostin and Dickkopf-1 correlate with vascular calcifications in non-dialysis chronic kidney disease 267
A CASE OF OSTEOPOROTIC FRACTURES IN WOLFRAM SYNDROME 257
Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis 244
Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity 232
As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration 230
AB0819 HANDGRIP STRENGTH PREDICTS HIGH FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 228
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 224
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 224
Correction to: Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride (Clinical Drug Investigation, (2018), 10.1007/s40261-018-0720-7) 222
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 221
Anxiety levels predict low bone mineral density in postmenopausal women assessed for osteoporosis. 218
ASSOCIAZIONE TRA IMPULSIVITÀ COGNITIVA E DENSITÀ MINERALE OSSEA: STUDIO CROSS-SECTIONAL SU DONNE VALUTATE PER OSTEOPOROSI POSTMENOPAUSALE 209
Applicazione quantitativa dell'ultrasonografia ossea quantitativa e dell'Hand grip nello screening per l'osteoporosi e per il rischio di frattura in donne in post-menopausa, condotto con l'algoritmo FRAX 202
Anabolic treatment with RHPTH of duchenne muscular dystrophy related osteoporosis: a case report 202
Bone mass and metabolism in patients with myastenia gravis: a possible anabolic role for pyridostigmine on bone tissue 195
Effects of long-lasting raloxifene treatment on serum prolactin and gonadotropin levels in postmenopausal women 194
BONE MASS AND BONE TURNOVER IN WOMEN WITH THALASSEMIA MAJOR RELATED OSTEOPOROSIS: EFFECTS OF STRONTIUM RANELATE 194
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 192
ASSOCIAZIONE TRA LIVELLI DI ANSIA E VITAMINA D IN DONNE IN ETÀ POSTMENOPAUSALE VALUTATE PER OSTEOPOROSI 189
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 188
Hyponatremia as a leading sign of hypopituitarism 187
Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors 185
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 185
SCLEROSTIN LEVELS IN TYPE 1 DIABETES MELLITUS: GENEDER DIFFERENCES AND ASSOCIATION WITH CLINICAL FEATURES 182
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 177
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 176
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 176
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 174
PULSED ELECTROMAGNETIC FIELDS AFFECT SCLEROSTIN LEVELS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 172
HANDGRIP STRENGHT AND PHALANGEAL QUANTITATIVE ULTRASOUND IN THE FRACTURE RISK ASSESSMENT OF POSTMENOPAUSAL WOMEN 171
Calcifediol improves lipid profile in osteopenic atorvastatin-treated postmenopausal women. 170
Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin 170
HEMOSTATIC VARIABLES IN ARTERIAL-HYPERTENSION 170
Deficit multiplo di AcilCoA deidrogenasi ad esordio tardivo. Descrizione di un caso clinico. 170
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 169
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 168
Descrizione di un caso di pielonefrite in ultranovantenne: complicanza extraintestinale di un fecaloma gigante. 167
Strontium ranelate improves bone mineral density in thalassemia major related osteoporosis and reduces sclerostin levels 166
Frailty and lipid profile in elderly hospitalized patients 166
Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride 165
EFFECTS OF DENOSUMAB ON QUATITATIVE ULTRASOUND AND DXA MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 165
Phalangeal quantitative ultrasound detects changes of bone status in aromatase inhibitor-treated breast cancer women. 164
IL-22 circulating serum levels in centenarians. 163
Healthy centenarians show high levels of circulating interleukin-22 (IL-22). 163
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 161
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 160
Vitamin D modulates bmd gain in postmenopausal women treated with strontium ranelate 160
Phalangeal quantitative ultrasound to investigate bone changes in aromatase inhibitor-treated breast cancer women receiving denosumab 159
Sclerostin in type 1 diabetes mellitus: gender differences and associations with clinical features, bone mass and metabolism 159
Cognitive impulsivity is associated with bone mineral density and history of falls in postmenopausal women. 159
Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate 159
Frailty modifications and prognostic impact in older patients admitted in acute care 157
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 156
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 156
ANXIETY SEVERITY AS A PREDICTOR OF OSTEOPOROSIS 156
VALUTAZIONE NEUROPSICOLOGICA IN SOGGETTI ANZIANI AFFETTI DA IPERTROFIA PROSTATICA BENIGNA IN TRATTAMENTO CON DUTASTERIDE 155
Sincope conseguente a severa depressione della conduzione atrio-ventricolare trattata con impianto di Pace-maker in un soggetto anziano affetto da fibrillazione atriale permanente e demenza in trattamento con rivastigmina 154
Fracture risk assessment in postmenopausal women referred to an Italian center for osteoporosis: a single day experience in Messina. 154
FRAGILITÀ E PROFILO LIPIDICO IN UN GRUPPO DI PAZIENTI ANZIANI OSPEDALIZZATI 154
Serum levels of Apelin-36 are decreased in older hospitalized patients with heart failure 153
SCLEROSTIN AND DICKKOPF-1 CORRELATE WITH VASCULAR CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 153
Effects of medium-term antihypertensive therapy on haemostatic parameters in patients with essential hypertension 151
SUBCLINICAL HYPERCORTISOLISM IS A RISK FACTOR TO BE EVALUATED IN THE ASSESSMENT OF BONE FRAGILITY? 151
Hemostasis and fibrinolysis factors in first-degree relatives of patients with type 2 diabetes without hypertension 150
BONE INVOLVEMENT IN DUCHENNE MUSCULAR DYSTROPHY 150
Valutazione e comparazione del filtrato glomerulare stimato con due differenti formule in una popolazione di centenari 149
Relationship between blood pressure and frailty in older hypertensive outpatients 149
Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis 149
Are Physicians Ready to Prevent Osteoporotic Fractures in Hemodialysis Patients? 148
Handgrip and phalangeal quantitative ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis. 148
Cognitive impulsivity is associated with bone mineral density in postmenopausal women evaluated for osteoporosis. 148
In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia 147
Electrocardiographic changes in centenarians: a study on 42 subjects and comparison with the literature 146
Estimating glomerular filtration rate in centenarians: comparison of the chronic kidney disease epidemiology collaboration (CKD-EPI) and modification of diet in renale disease (MDRD) study equation 146
Phalangeal quantitative ultrasound as assessment tool to evaluate bone loss in aromatase inhibitors related osteoporosis 146
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 145
Handgrip and phalangeal ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis 145
Does vitamin D3 have an impact on clinical and biochemical parameters related to third molar surgery 145
WNT/beta-CATENIN AND RANK/RANKL/OPG SIGNALLING MODULATES EFFECTS OF PULSED ELECTROMAGNETIC FIELDS ON BONE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 145
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 144
Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach 143
Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: New pieces of the puzzle 143
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 142
Calcifediol improves lipid profile in atorvastatin treated postmenopausal women 142
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 142
Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis 139
Impact of diabetes on cognitive impairment and disability in elderly hospitalized patients with heart failure 139
BONE MINERAL DENSITY MODIFICATIONS IN ACCORDANCE TO VITAMIN D STATUS IN POSTMENOPAUSAL WOMEN TREATED WITH STRONTIUM RANELATE 139
Impact of Premorbid IQ and Cognitive Reserve on Clinical and Functional Outcomes in Elderly Outpatients 139
Pulsed electromagnetic fields modulate bone metabolism via RANKL/OPG and Wnt/β-catenin pathways in women with postmenopausal osteoporosis: A pilot study 138
Osteoporosis and beta-thalassemia major: Role of the IGF- I/IGFBP-III axis 137
Cognitive Impairment and Slow Gait Speed in Elderly Outpatients with Arterial Hypertension: The Effect of Blood Pressure Values 137
Pulsed electromagnetic fields modulate sclerostin levels in women with postmenopausal osteoporosis 134
DISAPPEARANCE OF A VIRILIZING ADRENAL TUMOR FOLLOWING THERAPY WITH CYPROTERONE ACETATE. 133
Trabecular bone score and quantitative ultrasound measurements in the assessment of bone health in breast cancer survivors assuming aromatase inhibitors 133
HANDGRIP STRENGTH TO DISCRIMINATE HIGH FRACTURE RISK IN TYPE 2 DIABETES MELLITUS PATIENTS 133
Totale 17.283
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.952
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.952
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.293 0 183 21 54 33 9 106 39 122 210 127 389
2022/20233.155 225 332 153 206 307 286 21 175 1.314 15 88 33
2023/2024811 62 135 34 107 57 189 19 58 6 27 12 105
2024/20253.519 55 58 61 213 180 111 115 675 898 230 328 595
2025/202610.719 588 845 618 693 899 2.219 1.275 1.471 1.397 416 143 155
2026/20271.110 319 791 0 0 0 0 0 0 0 0 0 0
Totale 23.468